Ann: Australia Biotech Invest 2017 Presentation, page-98

I think the only thing wrong here is too much speculation on where sp should be which has created over expectation. Sp has hit its 6th higher low which to me sais our nest eggs are safe and growing.
Having said that, we have all seen frequent over selling on positive news.
We are still in spec space so this is likely to continue until we see a short term material ann. To answer whether sp will be punished on cfda or other substantial announcements, i highly doubt it as capper would be bought out very quickly as new money flushes them out.
All imo
Just happy to be a part of GMV i believe will be huge med to lt